"What" Series

What is Complete Response (CR) in Clinical Trials?

16 October 2023
2 min read

Complete response (CR) is defined as the absence of detectable tumor in the patient's body. Radiology and histopathology are used to measure CR, serving as surrogate or primary endpoints depending on the specific disease or use scenario.

Keep Reading
Back to all blogs →
Kineta Reports Encouraging Findings for KVA12123 Monotherapy from Phase 1/2 Clinical Study
Latest Hotspot
3 min read
Kineta Reports Encouraging Findings for KVA12123 Monotherapy from Phase 1/2 Clinical Study
16 October 2023
Kineta, Inc., a clinical-stage biotech firm specializing in unique cancer immunotherapies, has shared updates on their ongoing Phase 1/2 clinical trial of KVA12123 for advanced solid tumor patients.
Read →
What is Duration of Response (DoR) in Clinical Trials?
"What" Series
2 min read
What is Duration of Response (DoR) in Clinical Trials?
16 October 2023
Duration of Response (DoR) is defined as the time from randomization to disease progression or death for patients who achieve complete or partial alleviation.
Read →
Analysis on the Research Progress of Oncolytic virus
Advanced Tech.
6 min read
Analysis on the Research Progress of Oncolytic virus
16 October 2023
Oncolytic virus (OVs) refers to a generic name for viruses that naturally exist or are genetically edited to selectively kill tumor cells.
Read →
First participant receives Cu-67 SAR-Bombesin treatment in theranostic prostate cancer study
Latest Hotspot
3 min read
First participant receives Cu-67 SAR-Bombesin treatment in theranostic prostate cancer study
16 October 2023
Clarity Pharmaceuticals proudly announces the initial patient dosing in their 64Cu/67Cu SAR-Bombesin Phase I/II theranostic trial for patients with metastatic castrate resistant prostate cancer.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.